Brain health in your inbox!

Subscribe to our free emails

Sign Up Now


We provide you with articles on brain science, timely topics, and healthy living for those affected by neurologic challenges or seeking better brain health.  

Medication
By Christopher Gharibo, MD and Kriti Sankholkar, MD

Can Certain Antibiotics Cause Neuropathic Pain?

However, the connection between this commonly-used group of antibiotics—fluoroquinolones—and peripheral neuropathy is not yet fully understood.

Dr. Christopher Gharibo and Dr. Kriti Sankholkar respond:

Christopher Gharibo

Fluoroquinolones are an important group of antibiotics, commonly prescribed to treat infections for use at both home and in the hospital. However, they have been known to cause side effects, including dizziness and headache.

Most of the peripheral nervous system side effects have been described as mild and short in duration, although there have been numerous reports of severe and long-lasting peripheral neuropathies associated with fluoroquinolone use. Symptoms have been described as tingling, numbness, and sometimes "electrical" sensation; burning and shooting pain with night onset; increase in sensitivity to sensory stimuli (hyperesthesia); and symptoms associated with musculoskeletal pain. Patients reported that their symptoms lasted more than two weeks and caused functional limitations including impaired mobility, tendinitis, and disability. Although conclusive studies haven't been conducted to determine why fluoroquinolones may cause neuropathy, it has been found that symptoms completely resolved or improved upon the cessation of fluoroquinolone use.

Because there appears to be a positive correlation between fluoroquinolone use and neuropathic pain, any newly developing or worsening pain symptoms should be considered as a possible link to the fluoroquinolone treatment, and patients should be subsequently switched to another antibiotic.

Most of the data on fluoroquinolone use and the development of neuropathic pain have been gathered from self-reports. Although there are statistical problems with data collected in this manner, it's a start. In addition, it's difficult to determine which patients are at an increased risk for developing neuropathic pain; physicians therefore can't protect patients from potentially developing these symptoms. While it is clear that more studies need to be done to develop a clear picture on this issue, it's also possible that this problem may be more prevalent than we think.